Bafna Pharmaceuticals Ltd

📅 Bafna Pharmaceuticals Q3 FY2026 Results Board Meeting Scheduled

• Board meeting scheduled for February 11, 2026 to consider and approve un-audited financial results for Q3 ended December 31, 2025.

• Trading window closed for designated persons and their immediate relatives from January 1, 2026 to February 13, 2026 due to financial results consideration.